OTCMKTS:PRCNF

Pure Global Cannabis Stock Forecast, Price & News

$0.01
0.00 (-4.55 %)
(As of 04/12/2021 10:43 AM ET)
Add
Compare
Today's Range
$0.01
Now: $0.01▼
$0.01
50-Day Range
$0.01
MA: $0.02▼
$0.03
52-Week Range
$0.00
Now: $0.01▼
$0.32
Volume14,910 shs
Average Volume159,821 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Pure Global Cannabis Inc. produces cannabis products for the medical and adult-use markets in Canada. The company provides cannabis products, such as dried flower, cannabis oils, soft gels and capsules, seedlings and clones, vape pen cartridges, topicals, sublingual strip/spray, transdermal patch, and edibles and beverages, as well as wellness products. It offers its products under the PureSinse, SPARK Medical Cannabis clinics, and The Great Canadian Hemp Company brands. The company serves medical, pharmaceutical, wellness, health and beauty, natural health, food and beverage, and recreational legal markets. Pure Global Cannabis Inc. is headquartered in Toronto, Canada.
Pure Global Cannabis logo

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PRCNF
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.puresinse.com
Phone289-206-1552
Employees11
Year FoundedN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

Headlines

The U.S. May Be Ready to Move Forward with Cannabis Legalization
April 8, 2021 |  baystreet.ca
Dragon’s Den star’s CBD brand nets regulatory approval as it expands amid sector boom
April 7, 2021 |  msn.com
5 days to go! 3 penny stocks I’d buy before the Stocks and Shares ISA deadline
March 31, 2021 |  fool.co.uk
NA Proactive news snapshot: Loop Insights, XPhyto Therapeutics, Canada Silver Cobalt Works, KULR Technology, Todos Medical UPDATE...
March 29, 2021 |  proactiveinvestors.com
Pure Global Cannabis Inc. (OTCMKTS:PRCNF) Short Interest Up 327.0% in March
March 27, 2021 |  americanbankingnews.com
Benzinga Cannabis Hour Recap: There's A Need To Be 'More Vocal' To Help Women And People Of Color
March 15, 2021 |  benzinga.com
Stigma Grow Announces Sales License Partnership to Launch BevCanna's Portfolio of Cannabis-Infused Beverages and Products
March 15, 2021 |  markets.businessinsider.com
Rapidly Growing Cannabis Oil Market on Track to Create $41 Billion Opportunity
March 11, 2021 |  baystreet.ca
Pure Extracts and ShroomBloom Sign Psychedelic Mushroom Supply Letter of Intent
March 9, 2021 |  au.finance.yahoo.com
Cellular Goods, Kanabo, and MGC: should I buy these cannabis stocks?
March 8, 2021 |  fool.co.uk
Cannabis Oil Market Report Analysis, Size, Share, Revenue, Growth Rate With Forecast Overview 2021-2025 | Says Kenneth Research
March 5, 2021 |  marketwatch.com
The Cellular Goods share price slips. Is this Beckham-backed cannabis stock a buy?
March 3, 2021 |  fool.co.uk
Beginner's guide to investing in marijuana stocks and the booming cannabis industry
March 3, 2021 |  msn.com
Cannabis May Be the Hottest Investment Opportunity of the Year
February 25, 2021 |  baystreet.ca
Enveric Biosciences Launches Development Collaboration and Supply Agreement with PureForm Global to Support Cannabinoid Clinical Programs
February 25, 2021 |  markets.businessinsider.com
Cannabis Infused Edibles Market Could Exceed $11.5 Billion By 2025
February 16, 2021 |  marketwatch.com
Cannabis Testing Market Size, Growth and Share to Amass Commendable Returns By 2025
February 10, 2021 |  marketwatch.com
5 Reasons Why C21 Investments Is Ready To Take On The Big Cannabis MSOs
February 10, 2021 |  markets.businessinsider.com
This Top Cannabis CEO is Optimistic on U.S. Legalization
January 28, 2021 |  marketwatch.com
Simply Pure CEO Wanda James Wants Women To Brag More
January 27, 2021 |  benzinga.com
See More Headlines

MarketRank™

Overall MarketRank™

0.72 out of 5 stars

Medical Sector

1251st out of 2,016 stocks

Drug Manufacturers - Specialty & Generic Industry

24th out of 61 stocks

Analyst Opinion: 0.0Community Rank: 3.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.01
0.00 (-4.55 %)
(As of 04/12/2021 10:43 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PRCNF News and Ratings via Email

Sign-up to receive the latest news and ratings for PRCNF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Pure Global Cannabis (OTCMKTS:PRCNF) Frequently Asked Questions

What stocks does MarketBeat like better than Pure Global Cannabis?

Wall Street analysts have given Pure Global Cannabis a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Pure Global Cannabis wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Pure Global Cannabis?

Pure Global Cannabis saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 26,900 shares, an increase of 327.0% from the February 28th total of 6,300 shares. Based on an average trading volume of 63,100 shares, the days-to-cover ratio is currently 0.4 days.
View Pure Global Cannabis' Short Interest.

How has Pure Global Cannabis' stock been impacted by COVID-19?

Pure Global Cannabis' stock was trading at $0.0316 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, PRCNF stock has decreased by 66.8% and is now trading at $0.0105.
View which stocks have been most impacted by COVID-19.

Who are Pure Global Cannabis' key executives?

Pure Global Cannabis' management team includes the following people:
  • Mr. Malay Panchal, Founder, Pres, CEO, Treasurer & Director
  • Mr. Scott M. Langille CPA, CMA, MBA, Chief Financial Officer (Age 64)
  • Ms. Trupti P. Smit, Director of Corp. & Legal Affairs
  • Mr. Stephen Pynn, VP of Corp. Devel.
  • Mr. Ross J. Hendry, VP of Marketing
  • Mr. Michael Lavergne, Head of Global Supply Chain Services
  • Dr. Sanjeev Goel, Chief Medical Officer

Who are some of Pure Global Cannabis' key competitors?

Some companies that are related to Pure Global Cannabis include (THCX.V) (THCX), 31444 (GLH), 438280 (ACG), 815446 (HC), Abacus Health Products (ABAHF), Acreage (ACRGF), Althea Group (AGH), Applied Biosciences (APPB), AusCann Group (AC8), Ayr Strategies (AYRSF), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), Can B (CANB), Cannara Biotech (LOVE) and CannPal Animal Therapeutics (CP1).
View all of PRCNF's competitors.

What is Pure Global Cannabis' stock symbol?

Pure Global Cannabis trades on the OTCMKTS under the ticker symbol "PRCNF."

How do I buy shares of Pure Global Cannabis?

Shares of PRCNF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pure Global Cannabis' stock price today?

One share of PRCNF stock can currently be purchased for approximately $0.01.

How many employees does Pure Global Cannabis have?

Pure Global Cannabis employs 11 workers across the globe.

What is Pure Global Cannabis' official website?

The official website for Pure Global Cannabis is www.puresinse.com.

How can I contact Pure Global Cannabis?

The company can be reached via phone at 289-206-1552.


This page was last updated on 4/12/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.